Sabadell Asset Management’s Eli Lilly LLY Stock Holding History

Sabadell Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$1.53M	Hold	3,324	–	–	0.32%	58
2023 Q1	$1.2M	Buy	3,324 +421	+15%	+$142K	0.26%	71
2022 Q4	$1.05M	Sell	2,903 -297	-9%	-$105K	0.22%	89
2022 Q3	$1.06M	Sell	3,200 -484	-13%	-$153K	0.23%	76
2022 Q2	$1.2M	Hold	3,684	–	–	0.25%	81
2022 Q1	$1.14M	Sell	3,684 -8,679	-70%	-$2.23M	0.2%	107
2021 Q4	$3.09M	Buy	12,363 +543	+5%	+$138K	0.49%	62
2021 Q3	$2.73M	Sell	11,820 -31,544	-73%	-$7.79M	0.47%	65
2021 Q2	$9.95M	Buy	+43,364	New	+$8.71M	1.72%	12

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Sabadell Asset Management's LLY Position: Q2 2023 in Review

Sabadell Asset Management held its Eli Lilly (LLY) position steady in Q2 2023 at 3,324 shares worth $1.53M. The position accounts for 0.32% of the portfolio, ranked #58.

Sabadell Asset Management first reported a position in LLY in Q2 2021 and has held it in 9 quarters since. The position peaked at $9.95M in Q2 2021. 2,815 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

Sabadell Asset Management held 3,324 shares of Eli Lilly worth $1.53M as of Q2 2023.
Sabadell Asset Management left its Eli Lilly share count unchanged in Q2 2023.
Eli Lilly made up 0.32% of Sabadell Asset Management's portfolio in Q2 2023, its #58 holding.
Sabadell Asset Management first reported a position in Eli Lilly in Q2 2021 and has held it in 9 quarters since.
Sabadell Asset Management's Eli Lilly position peaked at $9.95M in Q2 2021.
2,815 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on Sabadell Asset Management's 13F filing for Q2 2023, filed 23 Jan 2024.